of the uniform tetrasaccharide linkage region is catalyzed by the xylosyltransferases I and II (XT-I, XT-II, EC 2.4.2.26) [7, 8, 9, 10] . These enzymes transfer a xylose residue from UDP-xylose to selected serine residues of the core protein and have been shown to catalyze the apparently rate-limiting step in glycosaminoglycan biosynthesis [7, 11, 12] . While being identified during a genetic screen for the XT-I cDNA sequences [13] , the enzymatic activity of XT-II remained elusive until the end of 2006 [10, 14, 15] . Both enzymes are capable of initiating chondroitin and heparan sulfate biosynthesis, and display some tissue-specific expression patterns [10, 15] . Although the xylosylation of the core protein occurs in the early Golgi compartments, the xylosyltransferases are being secreted into the extracellular space together with proteoglycans [16, 17] . Therefore, xylosyltransferase activity has been previously shown to be a reliable marker for the actual proteoglycan biosynthesis rate, which can be used for the assessment of tissue remodeling processes [16, 18, 19, 20, 21] .
A successful and efficient biosynthesis of proteoglycans during the chondrogenic differentiation of MSCs requires the coordinated expression of both the core protein and multiple glycosyltransferases and modifying enzymes. Therefore, we have investigated the expression of key enzymes involved in the synthesis of chondroitin sulfate, dermatan sulfate, and heparan sulfate proteoglycans during TGF-β 3 -induced chondrogenic differentiation of MSCs [22] . In order to differentiate between each pathway, expression of the key enzymes α4-N-acetylhexosaminyltransferase (EXTL2), β1,4-Nacetylgalactosaminyltransferase (GalNAcT), and glucuronyl C5 epimerase (GlcAC5E) was analyzed. EXTL2 transfers N-acetylgalactosamine and N-acetylglucosamine to the uniform tetrasaccharide linker, and is a key enzyme for the synthesis of heparan sulfate. GalNAcT initiates the synthesis of chondroitin sulfate and dermatan sulfate glycosaminoglycans by catalyzing the transfer of the first Nacetylgalactosamine to the tetrasaccharide linker. The epimerization of chondroitin sulfate to dermatan sulfate is catalyzed by GalNAcT. The TGF-β 3 -induced chondrogenic differentiation of MSCs resulted in the formation of cell aggregates that, after 28 days, showed a cartilage-like morphology. XT-I expression was up-regulated in early stages after TGF-β 3 -induced chondrogenic differentiation, while XT-II was increased in the late stages. This is concordant with other findings from our group where XT-I, but not XT-II, expression was up-regulated in TGF-β-induced fibrotic processes [7, 18] . It still has to be clarified whether this counterregulation of the xylosyltransferases leads to different proteoglycan patterns during chondrogenesis. Interestingly, all other glycosyltransferases showed a highly similar expression pattern, with a down-regulation in the early stages and a strong up-regulation after 1 week and more. The expression of major cartilage core proteins and type II collagen was considerably induced in the late stages of chondrogenic differentiation. All findings of the mRNA expression analysis could be paralleled with proteoglycan, glycosaminoglycan, or collagen content, as determined by enzyme activity, histochemistry, or immunostaining. The MSCs formed aggregates within 1 day after induction of chondrogenic differentiation and after 28 days, cryosections of the aggregates showed a condensed structure with chondrocyte-like lacunae after Safranin O staining, indicating the in vitro formation of cartilage.
The differentiation of MSCs into chondrocytes and the formation of intact cartilage with its important biomechanical properties require the coordinated biosynthesis of ECM components. The initiation of chondrogenesis leads to an induction of core proteins and glycosyltransferases involved in tetrasaccharide linker biosynthesis in the early stages of cell differentiation, while chain-elongating enzymes and type II collagen are rather up-regulated in later stages. These findings show a coordinated expression of genes involved in proteoglycan and collagen biosynthesis, although the underlying regulatory pathways have not been elucidated in detail. As proteoglycans have been shown to support collagen fibril formation in the ECM and both components are subject to cross-talk in the matrix network, the coordinated expression is supposed to be necessary for the formation of functional cartilage. While tissue-engineered cartilage has only limited biomechanical capacities compared to articular cartilage transplants, a modulation of these pathways might lead to an improved ECM formation and, consequently, overcome these limitations of in vitro-generated cartilage. This modulation of the proteoglycan biosynthesis pathway during the in vitro formation of articular cartilage could be achieved, e.g., by the addition of growth factors and cytokines, which are known as inducers of proteoglycan expression. Optimized cultivation and differentiation media containing these factors, e.g., from the TGF superfamily, would result in an enhanced expression of proteoglycans and other ECM molecules, leading to engineered cartilage with improved biomechanical properties and a broad range of therapeutic indications.
